These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 4459479)

  • 21. [Correlations between the histological changes and results of treatment with corticoids and immunosuppressive agents in primary glomerulonephritis].
    Lagrue G; Bariety J
    Minerva Med; 1970 Jul; 61(55):3054-63. PubMed ID: 5427678
    [No Abstract]   [Full Text] [Related]  

  • 22. Alternate-day steroid therapy in adult nephrotics.
    Gulati PD; Malik GB; Vaishnava H
    J Med; 1973; 4(5):266-75. PubMed ID: 4589645
    [No Abstract]   [Full Text] [Related]  

  • 23. [Treatment of acute glomerulonephritis in middle-aged patients].
    Kuznetsova OP; Vorob'ev PA; Dvoretskiĭ LI; Chistova VS; Fedorova EA
    Ter Arkh; 1987; 59(8):128-31. PubMed ID: 3686437
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [New approaches to therapy in glomerulonephritis patients].
    Riabov SI; Rakitianskaia IA; Stavskaia VV; Nikitina NA
    Ter Arkh; 1996; 68(6):24-7. PubMed ID: 8771678
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Steroid-sensitive nephrotic syndrome associated with positive C1q immunofluorescence.
    Hashimoto S; Ogawa Y; Ishida T; Mochizuki T; Koike T; Sato H; Ueda T
    Clin Exp Nephrol; 2004 Sep; 8(3):266-9. PubMed ID: 15480906
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term follow-up study of IgM associated nephrotic syndrome patients: clinical outcome and prognostic indicators.
    Kurathong P; Jesdapatarakul S
    J Med Assoc Thai; 2000 Mar; 83(3):315-24. PubMed ID: 10808687
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Steroid and immunosuppressive therapy in primary glomerular nephropathy (glomerulonephritis) in adults. Clinical and nephrobioptic study].
    Bonomini V; Mioli V; Albertazzi A; Vangelista A
    Minerva Nefrol; 1969; 16(2):103-19. PubMed ID: 5398499
    [No Abstract]   [Full Text] [Related]  

  • 28. [Evaluation of steroid resistant patients].
    Tamura T; Takashima K; Hatta I; Ogawa H; Tominaga K
    Nihon Rinsho; 1968 May; 26(5):1132-44. PubMed ID: 5749791
    [No Abstract]   [Full Text] [Related]  

  • 29. [On the use of indomethacin in the treatment of renal diseases in childhood].
    Varese LA; Antoniola P
    Minerva Pediatr; 1970 Jul; 22(28):1440-3. PubMed ID: 5515768
    [No Abstract]   [Full Text] [Related]  

  • 30. [Anti-proteinuric effect of indomethacin in glomerulopathies (nephrotic syndrome, acute glomerulonephritis and chronic glomerulonephritis). Preliminary note].
    Conte J; Suc JM; Mignon-Conte M
    J Urol Nephrol (Paris); 1967; 73(10):850-6. PubMed ID: 5596281
    [No Abstract]   [Full Text] [Related]  

  • 31. [Therapeutic effect of cyclophosphamide in patients with chronic glomerulonephritis with nephrotic syndrome].
    Duman VL
    Ter Arkh; 2002; 74(6):39-41. PubMed ID: 12136481
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Treatment of chronic glomerulonephritis with imuran].
    Kämpfen P; Hodler J
    Schweiz Med Wochenschr; 1970 Dec; 100(49):2093-100. PubMed ID: 5495326
    [No Abstract]   [Full Text] [Related]  

  • 33. Prednisolone and azathioprine in membranous nephropathy: a 10-year follow-up study.
    Goumenos DS; Ahuja M; Davlouros P; El Nahas AM; Brown CB
    Clin Nephrol; 2006 May; 65(5):317-23. PubMed ID: 16724651
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Red cell distribution width in primary glomerulonephritides.
    Balta S; Aparci M; Demirkol S; Ozturk C; Celik T
    Ren Fail; 2015 Mar; 37(2):358. PubMed ID: 25644969
    [No Abstract]   [Full Text] [Related]  

  • 35. Nephrotic syndrome due to primary renal disease in adults: II. A controlled trial of prednisolone and azathioprine.
    Sharpstone P; Ogg CS; Cameron JS
    Br Med J; 1969 May; 2(5656):535-9. PubMed ID: 4890207
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Study of morphological types of nephrotic glomerulonephritis and the number of glucocorticoid receptors of lymphocytes for prognosis of the effectiveness of glucocorticoid therapy].
    Sasu BI; Mukhin NA; Serov VV; Varshavskiĭ VA
    Arkh Patol; 1984; 46(6):21-6. PubMed ID: 6383286
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Nephrotic syndrome as a leading symptom of glomerulonephritis in the aging man].
    Kellner K; Wüst I
    Med Klin; 1970 Dec; 65(52):2285-9. PubMed ID: 5522669
    [No Abstract]   [Full Text] [Related]  

  • 38. [Effect of heparin on proteinuria and other biochemical parameters in nephrotic syndrome].
    Poplawski A
    Pol Tyg Lek; 1974 Mar; 29(10):289-91. PubMed ID: 4826144
    [No Abstract]   [Full Text] [Related]  

  • 39. The treatment of chronic mesangiocapillary (membranoproliferative) glomerulonephritis with impaired renal function.
    Kincaid-Smith P
    Med J Aust; 1972 Sep; 2(11):587-92. PubMed ID: 5082784
    [No Abstract]   [Full Text] [Related]  

  • 40. Nephrotic syndrome in two members of a family with mercury poisoning.
    Meeks A; Keith PR; Tanner MS
    J Trace Elem Electrolytes Health Dis; 1990 Dec; 4(4):237-9. PubMed ID: 2136288
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.